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Introduction {#sec1}
============

Membrane fluidity has been classically considered a key physical property affecting cell adhesion ([@bib14], [@bib31], [@bib32], [@bib39]) and communication ([@bib30], [@bib48]). For example, cellular adhesion has been shown to be regulated by the nanocluster formation of adhesion complex-associating ordered lipid rafts ([@bib11], [@bib34]); thus, the ease of lateral membrane protein diffusion in optimum membrane fluidity reflects the adhesion characteristics ([@bib9], [@bib28]). Both studies indicate that membrane fluidity can be the more generic parameters influencing biological function of cells over adhesion characteristics. Given the important role of lipid membranes (i.e., membrane fluidity) in biological function such as cell adhesion, previous studies have characterized the fluidic properties of human primary neurons ([@bib5], [@bib22]), while others have examined the lipidomic profiles of lysed hepatocyte-like cells ([@bib16]). However, limited numbers of studies have been performed to address its cell-type-specific signatures, especially in the context of stem cell biology; thus, the comprehensive characterization of membrane fluidity in various lineages is essential for gaining key membrane insights into cellular identity and differentiation.

Classical "panning" method is a simplified technique for effective bulk cell purification based on differential adhesion kinetics ([@bib7], [@bib17], [@bib44]), waiving antibody-based separation such as fluorescence-activated cell sorting and magnetic-activated cell sorting (MACS). Interestingly, [@bib33] developed the microfluidic device to eliminate pluripotent stem cell colonies that are sensitive to shear stress and separated from differentiated progeny. Therefore, we hypothesized the cell-type-specific adhesion capacity, if it exists, can be rendered to be an effective and simple panning approach without requiring flow devices or depending on colony morphology for the purification of "early" differentiated progeny from heterogeneous cell mixtures.

Here, we revisited the panning concept by modulating the membrane fluidity of pluripotent membrane and established an adhesion sorting (AdSort) method. Natural polyphenols modulate the pluripotent membrane signature so as to reduce the cell adhesion without any toxic effects relative to its early differentiated progeny. Although the purity and sensitivity of this method is not so comparable with an antibody-based approach, the AdSort method will likely be a complementary separation method for cell manufacturing due to its minimal time, toxicity, and cost.

Results {#sec2}
=======

Membrane Rigidification Prior to Pluripotency Exit of Human iPSCs {#sec2.1}
-----------------------------------------------------------------

To evaluate the time-progression of membrane fluidity during pluripotency exit and differentiation ([Figure 1](#fig1){ref-type="fig"}A), laurdan ([@bib10], [@bib25], [@bib26], [@bib42]) was applied to obtain generalized polarization (GP) as an index of membrane fluidity. The native membrane of pluripotent and pre-/post-differentiated cells showed comparable GP during endodermal induction ([Figure 1](#fig1){ref-type="fig"}B, left). In contrast, the cholesterol-depleted membrane obtained by methyl-beta-cyclodextrin (MβCD) ([@bib45], [@bib50])^,^ treatment revealed a distinguishable fluidic signature for the pluripotent membrane (red in the GP image) from that of the early differentiated progeny ([Figures 1](#fig1){ref-type="fig"}B, right and [S1](#mmc1){ref-type="supplementary-material"}A). It should be noted that such abrupt decrease in GP of pluripotent membrane is not influenced by the induced pluripotent stem cell (iPSC) lines ([Figures S1](#mmc1){ref-type="supplementary-material"}E and S1F). The results indicated that the membrane signature of iPSCs (highly cholesterol content) is not influenced by the donor differences. Quantitative fluidic analysis of the cholesterol-depleted membrane of human iPSCs during endodermal induction confirmed the progressive rigidification of lipids (red) and decrease in cholesterol (blue, [Figure 1](#fig1){ref-type="fig"}C, upper), resulting in a gradual increase in ordered lipid level ([Figure 1](#fig1){ref-type="fig"}C, lower).Figure 1Membrane Rigidification Prior to Pluripotency Exit(A) Flow cytometry analysis of pluripotent cells during endodermal induction. A differentiation marker (CXCR4, marker of definitive endoderm cells) and a pluripotent marker (Tra2-49/6E) were used.(B) Representative GP images of pluripotent and pre-/post-differentiation cells in the absence/presence of MβCD. Pre-/post-differentiation cells were obtained at days 3 and 5 during endodermal induction, respectively.(C) Statistical analysis of the mean GP during endodermal induction in the absence (gray) and presence (red) of MβCD and the calculated cholesterol level (blue). Estimated membrane composition is schematically illustrated in the lower panel.(D) Differentiation (CXCR4) and pluripotency marker (tra2-49/6E) is co-plotted with GP (+MβCD) during induction. Error bars originate from three independent experiments (n = 3).(E) Microarray analysis of SCD1/hydroxymethylglutaryl-CoA reductase (HMG-CR) expression in iPSCs during endodermal induction, which was reanalyzed data of our previous study ([@bib36]).(F) Concentration dependence of CAY10566 (inhibitor of unsaturated lipid synthesis, SCD1) and lovastatin (inhibitor of cholesterol synthesis, HMG-CR) on pluripotency. Error bars originate from the SD of the histograms of Tra2-49/6E expression.(G) Phosphorylated-Smad2/3 expression of pluripotent cells in the presence and absence of fluidic modulators.(H) Estimated role of SCD1 and HMG-CoA reductase in the maintenance of pluripotency.Error bars show the standard deviation.

Interestingly, such lipid rigidification preceded the exit of pluripotency, based on pluripotency marker analysis by flow cytometry (FCM) (Tra2-49/6E, [Figures 1](#fig1){ref-type="fig"}D, [S1](#mmc1){ref-type="supplementary-material"}B, and S1C in detail), indicating a higher specificity to pluripotent state than surface marker profiling. mRNA levels of the other pluripotency marker sets (Oct4/Nanog/Sox2) were analyzed by qPCR during endodermal induction ([Figure S1](#mmc1){ref-type="supplementary-material"}D). Although, of these markers, the SOX2 expression level decreases at almost the same timescale as membrane rigidification, overall membrane fluidity changes precede the downregulation of the other markers. In agreement with this, the timeline of pluripotency exit is similar to endodermal induction of human embryonic stem cells ([@bib41]) and murine iPSCs ([@bib1]), and mesodermal induction of mouse embryonic stem cells ([@bib49]). To assess the origin of membrane rigidification dynamics, key fluidity determinants, (1) lipid and (2) cholesterol biosynthetic pathways, were assessed. Regarding lipid synthesis, stearoyl-coA desaturase (SCD1) was proposed as a prominent enzyme converted into fluidic unsaturated oleic acid, leading to the proliferation of pluripotent cells ([@bib3]). Microarray analysis confirmed the SCD1-specific expression of pluripotent cells ([Figure 1](#fig1){ref-type="fig"}E, left). Addition of an inhibitor (CAY10566) at a milder concentration (\<500 nM) strongly decreased the pluripotency level ([Figure 1](#fig1){ref-type="fig"}F) without affecting viability ([Figure S2](#mmc1){ref-type="supplementary-material"}B, left). In the case of cholesterol synthesis, microarray analysis showed the high expression of hydroxymethylglutaryl- coenzyme A (CoA) reductase ([@bib12]) in pluripotent cells ([Figure 1](#fig1){ref-type="fig"}E, right). Thus, mild treatment with the inhibitor lovastatin (\<833 nM) also accelerated exit from pluripotency ([Figure 1](#fig1){ref-type="fig"}F) without affecting viability ([Figure S2](#mmc1){ref-type="supplementary-material"}B, right).

Does such a change in membrane composition affect transmission of differentiation stimuli? To test this, the phosphorylation of Smad2/3 activated by activin ([@bib27]) was monitored in the presence of lipid-composition modulators ([Figure 1](#fig1){ref-type="fig"}G). Cholesterol depletion and fatty acid insertion produced a four times greater silent fraction (17%--28%), with 32 times quicker reaction than activin receptor inhibition ([Figures S2](#mmc1){ref-type="supplementary-material"}E and S2F). This silencing could originate from the restriction of receptor movement under the conditions of optimal physical membrane properties ([@bib30]). These results indicate that membrane composition to pluripotent state is unique, as shown in previous studies on cancer cell lines ([@bib2], [@bib8], [@bib29], [@bib47]), and the exit from pluripotency significantly alters its composition, which might sensitize collective cells to differentiation stimuli ([Figure 1](#fig1){ref-type="fig"}H).

Presence of Lineage-Specific Membrane Fluidity Signatures {#sec2.2}
---------------------------------------------------------

Next, to assess whether the membrane fluidity fingerprint is unique to the other cell states, we systematically evaluated the membrane property of pluripotent cells and the early differentiated progeny, including definitive endoderm (DE) cells, hepatic endoderm (HE) cells, endothelial cells (ECs), mesenchymal cells (MCs), and neural crest (NC) cells, covering all three germ layers ([Figure 2](#fig2){ref-type="fig"}A). To assess the lineage specification, gene expression analysis of CXCR4/CER1 (DE), HNF4α (HE), and AFP/ALB (MH), and FCM analysis of CD31/CD144 (EC) and CD166/CD90 (MC) were routinely confirmed as described previously ([@bib37]). Interestingly, in contrast to iPSCs or mesodermal derivatives, the native membrane of later endoderm/ectoderm cells was clearly recognized as rigidized ([Figure 2](#fig2){ref-type="fig"}A, left). Upon cholesterol depletion by MβCD, the mesodermal membrane clearly rigidized, whereas the pluripotent membrane fluidized compared with that of the other early differentiating progeny. Quantitative GP histograms of the cholesterol-depleted (red) or native membrane presented in a radar plot indicated that the pluripotent state also showed lipid disorder (peak position, red arrow) with a high cholesterol content (blue arrow) compared with the endodermal state, and such tendency was preserved for the mesoderm and ectoderm states ([Figure 2](#fig2){ref-type="fig"}B, original histograms in [Figures S3](#mmc1){ref-type="supplementary-material"}A and S3B). These results indicated the presence of a distinct physical membrane fingerprint, i.e., a membrane fluidity signature, for pluripotent cells and early differentiated progeny in terms of the (1) native lipid order level (iPSCs ≪ MCs \< NC cells \< HE cells) and (2) cholesterol level (iPSCs ≫ ECs ∼ MCs ∼ NC cells \> HE cells). Thus, the fluidity measurement of native and/or cholesterol-depleted membranes revealed the presence of lineage-specific membrane fluidity signatures, which are temporally regulated throughout cellular differentiation.Figure 2Lineage-Specific Membrane Fluidity Signatures(A) Representative GP images of pluripotent cell derivatives with different germ layer origins in the absence/presence of MβCD. Early differentiated progeny was induced and characterized with specific markers according to established protocols ([@bib37]). Pluripotent, iPSC; endoderm, HE; mesoderm, MC; ectoderm, NC.(B) GP radar plot of iPSCs and derivatives covering all germ layer origins. Dotted arrows show the maximum peaks in the presence (red) and absence (blue) of MβCD. Solid arrows show the differences between the red and blue ends, representing the cholesterol level. Three independent experiments were performed (n = 3, raw histograms are displayed in [Figures S3](#mmc1){ref-type="supplementary-material"}A and S3B).

Fluidity Modulator Screening for Pluripotent Membrane {#sec2.3}
-----------------------------------------------------

Classical studies have revealed that surfactants fluidize the cell membrane, weakening cell adhesion ([@bib14], [@bib32], [@bib38]); however, such toxic modification renders the cells unusable ([@bib40]). Although MβCD strongly magnifies these potential differences ([Figure 1](#fig1){ref-type="fig"}), such a strong depletion of cholesterol reduces cell viability, which is a critical problem for their actual use after characterization. To identify specific fluidic modulators for pluripotent cells without significantly affecting the function and viability of targeted differentiated progeny ([Figures S4](#mmc1){ref-type="supplementary-material"}D--S4F), we screened a self-built small-molecule library combined with an image-based fluidity determination assay and identified polyphenol as a potential augmenter ([Figure 3](#fig3){ref-type="fig"}A). The GP (vertical axis) values of the iPSC membrane in the presence of small molecules (horizontal axis) were plotted with z-color strength as *F*~*reacted*~ = *F*~*after*~ − *F*~*before*~ to identify effective molecule. *F* is frequency in the histogram before (*F*~*before*~) and after (*F*~*after*~) reaction with small molecules. To further confirm that the identified polyphenols act as fluidic modulators specifically for the pluripotent membrane, *F*~*difference*~ = *F*~*differentiated*~ − *F*~*pluripotent*~ were plotted as GP values in the absence (control) and presence of 100 μM polyphenols ([Figure 3](#fig3){ref-type="fig"}B). Stronger modulators (curcumin/genistein) especially enhanced the differences, with 4-fold greater positive area ([Figure 3](#fig3){ref-type="fig"}C). These results indicate that fluidity differences between pluripotent cells and early differentiated progeny were successfully augmented by the natural polyphenols.Figure 3Identification of Polyphenols as a Fluidic Modulator for Pluripotent Membrane(A) Fluidity-based drug screening for iPSC fluidic modulators. The power of *F*~*reacted*~ = *F*~*after*~−*F*~*before*~ is plotted as GP and small molecules.(B) *F*~*difference*~*= F*~*differentiated*~ − *F*~*pluripotent*~ is plotted as GP in the absence/presence of polyphenols. Higher *F*~*difference*~ indicates that the histograms from differentiated cells are dominant.(C) Summation of positive area in (B).

AdSort Method for Cell Purification {#sec2.4}
-----------------------------------

Given that membrane fluidity plays key roles to regulate the subsequent biological function, we further aimed to devise a practical methodology for label-free cell purification by using the cell adhesion characteristics, which are a more specific physical parameters under membrane fluidity. We initially evaluated adhesion differences between two distinct differentiation stages as an elimination ratio with empty (supernatant) and filled (substrate) balloons ([Figure 4](#fig4){ref-type="fig"}A). Balloon arrays combining fluidity modulators (i.e., solute), conventional adhesion regulators (i.e., time and matrix), and weakly/strongly adhered conditions were obtained after screening 1,150 different conditions, identifying arrays of specific conditions to separate out specific early progenitors from iPSCs ([Figure 4](#fig4){ref-type="fig"}B). Interestingly, cell lineage-specific adhesion strength order was summarized as *F*~*HE*~ *\< F*~*iPSC*~ *\< F*~*MC*~. Adhesion strength of differentiated fibroblast has been known to be stronger than those of iPSCs ([@bib46], i.e., F~*iPSC*~ \< F~*MC*~). In contrast, adhesion strength of late stage definitive endodermal cells showed gradual decreases according to the specific integrin subtypes ([@bib23], i.e., *F*~*HE*~ *\< F*~*iPSC*~). Although both studies support the obtained order of adhesion strength, further studies are necessary to provide the conclusive answer.Figure 4Purification of Differentiated Progeny from Pluripotency by Fluidity Signature Sorting(A) Schematic protocols for the cell purification experiment.(B) Balloon plot of the elimination ratio of iPSCs from differentiated cells.(C) Quantitative analysis of flow cytometry analysis of cells with high Tra2-49/6E expression (day 1) and albumin secretion at day 18. The definitions are given in the legend to [Figure S3](#mmc1){ref-type="supplementary-material"}C. The error bars originate from three independent experiments.(D) Representative adhesion kinetics of pluripotent cells and early differentiated progeny (endoderm, HE; mesoderm, EC) in the absence/presence of polyphenols (100 μM genistein). Proposed mechanism for enhancing fluidity and adhesion differences between pluripotent cells and early differentiated progeny. The error bars originate from three independent experiments (n = 3).Error bars show the standard deviation.

The safety and functionality of separated cells were tested. Most importantly, AdSort using curcumin lowers initial pluripotency levels of HE (50% spiked) under the control ([Figure 4](#fig4){ref-type="fig"}C, left dark arrows) according to FCM analysis ([Figures S3](#mmc1){ref-type="supplementary-material"}C--S3E) with the resultant high cell recovery ratio (∼80%, [Figure S4](#mmc1){ref-type="supplementary-material"}C). Moreover, curcumin lowered the coverage ratio of iPSCs (GFP labeled) ([Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B). For functional analysis, equal volumes of iPSCs and iPSC-hepatic endoderm cells were mixed, and albumin secretion of separated hepatic endoderm cells was evaluated after AdSort-based cell separation ([Figure 4](#fig4){ref-type="fig"}C, right). For all conditions, the weakly adhered cells secreted higher albumin levels, indicating functional HE cell enrichment in the supernatant. Regarding the other lineages, polyphenol-based separation, in this case genistein, preserves the cells with plug formation capacity or contraction capacity, which are typical characteristics of ECs ([Figure S4](#mmc1){ref-type="supplementary-material"}D) or MCs ([Figure S4](#mmc1){ref-type="supplementary-material"}E), without significantly altering their viability ([Figure S4](#mmc1){ref-type="supplementary-material"}F). Moreover, separated endothelial and MCs under various incubation times facilitated liver organoid formation and supported the enhancement of albumin secretion ([Figures S4](#mmc1){ref-type="supplementary-material"}G and S4H). Hence, these results suggest to confirm the minimal invasiveness of our system. Of note, polyphenols specifically reduced the adhesion of pluripotent cells but not other differentiated progeny, leading to an increased difference in adhesion kinetics ([Figure 4](#fig4){ref-type="fig"}D, left). The shape of *F*~*difference*~ ([Figure 3](#fig3){ref-type="fig"}B) resembles that of the cholesterol-depleted membrane ([Figure S3](#mmc1){ref-type="supplementary-material"}B, bottom), suggesting that polyphenols interact with membranes with fluidic lipids and cholesterol confirmed by model membrane experiments ([Figure 4](#fig4){ref-type="fig"}D, right) ([@bib13], [@bib15], [@bib19], [@bib21], [@bib24], [@bib35]).

Discussion {#sec2.5}
----------

Membrane fluidity influences stem cell maintenance and differentiation, possibly through the modulation of intra-cellular signaling transmission. For example, the ease of ephrin constriction in fluidic membranes augments internal signaling ([@bib30]). Here, a stimulated change in the membrane composition transmitted to internal signaling is a comparably short timescale relative to that of conventional phosphorylation inhibitors ([Figures S2](#mmc1){ref-type="supplementary-material"}C--S2F). These results potentially led us to the hypothesis that membrane rigidification can be transmitted to neighboring cells, resulting in the explosive acceleration of a differentiation wave. [@bib30] emphasized that intermembrane signaling is initially triggered by the clustering of adhesion ligands in the fluid membrane. Such physical connections among cells with different fluidic membrane potentials can strengthen cell-cell signaling, leading to the "relay" of membrane fluidity signatures. Further studies, such as those using the model membrane system ([@bib30]), will further delineate the presence of fluidic relays during the stem cell differentiation.

Experimental Procedures {#sec3}
=======================

Materials {#sec3.1}
---------

Deionized water from a Milli-Q device (Millipore, Molsheim, France) was used throughout this study. Unless stated otherwise, all other chemicals were purchased either from Sigma-Aldrich (Tokyo, Japan), Invitrogen (Tokyo, Japan), or Wako (Tokyo, Japan). Pure chemicals (Tokyo, Japan) and were used without further purification.

Cell Culture and Differentiation {#sec3.2}
--------------------------------

All procedures involving the use of human stem cell were approved by ethics commission of Yokohama City University and Tokyo Medical and Dental University.

FfI01, NcGMP1 (ET), and FfI14S04 (M66) human iPSC clones used in this study were kindly provided by CiRA (Kyoto, Japan) and Dr. Xianmin Zeng (XCell, CA, USA). Undifferentiated human iPSCs were maintained on laminin 511 (imatrix-511, nippi)-coated plastic dishes. For germ layer differentiation, we followed slightly modified protocols. DE cells, HE cells, MH, ECs, MCs were obtained based on modified previous protocols ([@bib6], [@bib37]), and NC cells were obtained based on previous protocols. To confirm the fluidic signature of iPSCs (high cholesterol content), four cell lines were used ([Figure S2](#mmc1){ref-type="supplementary-material"}). For the demonstration of the AdSort impact on the cell purification, a single-cell line (FFI01) was used combining 1,150 screening conditions. Obtained optimal condition for the purification of cell sources possibly depends on the iPSC lines; however, such dependency can be clarified by using our AdSort method in future studies.

Fluidity Measurements {#sec3.3}
---------------------

For the quantitative evaluation of cell membrane fluidity, we basically followed well-established protocols ([@bib10], [@bib25], [@bib26]). In brief, dimethyl-6-dodecanoyl-2-naphthylamine (laurdan, AdipoGen Life Science, CA, USA) was selected as a fluidity probe and dissolved into a DMSO solution (9 mM final). The final concentration of the probe was constant (33 μM final) in RPMI 1640 medium (+10 mM MβCD) and StemFit AK02N culture medium. Cells were incubated in the media for 30 min at 37°C and then observed by confocal microscopy (TCS-SP8, Leica microsystems, Tokyo, Japan) with a 37°C incubation chamber (Tokken, Tokyo, Japan). A 405-nm laser diode was utilized as a light source, and the fluorescence intensity at λ = 406--460 nm (*I*~406−460~) or λ = 470--530 nm (*I*~470−530~) was obtained by the spectrum analyzer inside the confocal unit. To evaluate the cell membrane fluidity quantitatively, GP values were defined:$${GP} = \ \frac{I_{406 - 460} - G \times I_{470 - 530}}{I_{406 - 460} + G \times I_{470 - 530}}$$$$G = \ \frac{GP_{ref} + GP_{ref}GP_{mes} - GP_{mes} - 1}{GP_{mes} + GP_{ref}GP_{mes} - GP_{ref} - 1} = \frac{GP_{meas} + 1}{GP_{meas} - 1} \div \frac{GP_{ref} + 1}{GP_{ref} - 1}$$Here, *GP*~*ref*~ = 0.207, the convention in the literature, was defined as a reference GP value^3^ such that GP values for model membranes with areas of liquid-ordered and -disordered phases separated at around GP = 0. *GP*~*meas*~ was calculated by measuring laurdan in DMSO (33 μM) using the same microscopic setup, as follows:$$GP_{mes} = \ \frac{I_{406 - 460} - I_{470 - 530}}{I_{406 - 460} + I_{470 - 530}}\quad G = 1\text{,}\ $$

Spike Measurements {#sec3.4}
------------------

To obtain the elimination ratio of [Figure 4](#fig4){ref-type="fig"}B, GFP-labeled iPSCs were spiked with differentiated cells at a ratio of 1:1 (3 × 10^5^ in total, 300 μL in final volume). The suspension was seeded on 48-well plates (Falcon) and incubated at 37°C to examine various factors, including time, solute, and matrix. To coat the matrix protein on the well surface, the wells were pre-incubated for 30 min in the concentration used for the induction of differentiation: ×1 gelatin (0.09 mg/cm^2^), ×1 fibronectin (0.91 μg/cm^2^), ×1 laminin (0.24 μg/cm^2^), ×1 Matrigel (7.14 μg/cm^2^), and ×1 collagen (0.91 μg/cm^2^). The solute stock solution was dissolved in ethanol (120 mM final). The iPSC elimination ratio of the mixtures was calculated using [Equations 4](#fd4){ref-type="disp-formula"} and [5](#fd5){ref-type="disp-formula"}:$${Elimination~ratio} = \ \frac{Contamination\ ratio_{base} - Contamination\ ratio_{measured}}{Contamination\ ratio_{base}}$$$$Contamination\ ratio_{measured} = \frac{Number\ of\ cells_{green\ channel}}{Number\ of\ cells_{phase\ channel}}$$Here, *contamination ratio*~*base*~ is 50% due to the 1:1 mixture of the green iPSCs and differentiated cells. Thus, the strength of the elimination ratio ranged from −100 (supernatant elimination) to approximately +100% (adhesion elimination), which are the limits for eliminating the iPSCs from the suspension. It should be noted that the phase and fluorescence images of the wells were captured by an automated microscope (Keyence, USA), and the number of cells was counted by the Keyence counting program. For further chemical fixation methods ([@bib4]), live imaging dyes ([@bib18]) were not used thus avoiding significant effects on viable cell adhesion.

For further differentiation of separated hepatic endoderm, which was spiked with iPSCs in [Figure 4](#fig4){ref-type="fig"}C, strongly adhered cells were incubated in the differentiation medium (Hepatocyte Culture Media BulletKit, HCM, Lonza, Tokyo, Japan) with 1 μM rock inhibitor and laminin (1× concentration). Weakly adhered cells in the supernatant were quenched by adding 300 μL of the culturing differentiation medium. All the culture media were exchanged on days 1, 4, and 7, and the albumin concentration of supernatant was measured on day 10. The iPSC coverage ratio in [Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B was calculated according to [Equation 6](#fd6){ref-type="disp-formula"}:$${iPSC~coverage~ratio} = \frac{Area\ of\ iPSCs_{green\ channel}}{Total\ cell\ area_{phase\ channel}}$$

It should be noted that the culture conditions at the day 0 (immediately after the separation) were set to favor iPSCs: (1) rock inhibitor (1 μM) suppressed iPSC apoptosis after separation ([@bib43]) and (2) the presence of laminin 511 facilitated iPSC adhesion ([@bib20]).
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